Citigroup Cuts Mettler-Toledo International (NYSE:MTD) Price Target to $1,550.00

Mettler-Toledo International (NYSE:MTD) had its target price decreased by equities research analysts at Citigroup from $1,700.00 to $1,550.00 in a report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the medical instruments supplier’s stock. Citigroup’s price objective would indicate a potential upside of 38.01% from the company’s current price.

A number of other research analysts have also recently commented on the stock. Morgan Stanley dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a report on Tuesday, February 10th. Wall Street Zen upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Barclays dropped their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Finally, Jefferies Financial Group upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and raised their price objective for the company from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $1,447.08.

Mettler-Toledo International Stock Down 14.9%

Shares of MTD stock traded down $196.21 on Friday, reaching $1,123.08. The company had a trading volume of 536,457 shares, compared to its average volume of 155,064. The stock has a market capitalization of $22.74 billion, a PE ratio of 26.66, a price-to-earnings-growth ratio of 2.78 and a beta of 1.31. Mettler-Toledo International has a one year low of $1,079.34 and a one year high of $1,525.17. The business’s 50-day moving average is $1,276.49 and its 200 day moving average is $1,367.66.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. The firm had revenue of $947.13 million during the quarter, compared to analysts’ expectations of $943.14 million. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, sell-side analysts forecast that Mettler-Toledo International will post 46.51 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the transaction, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.71% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in MTD. Norges Bank bought a new position in Mettler-Toledo International during the 4th quarter worth approximately $520,989,000. M&T Bank Corp raised its holdings in Mettler-Toledo International by 2,813.6% during the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock worth $173,165,000 after purchasing an additional 119,942 shares during the last quarter. Capital International Investors raised its holdings in Mettler-Toledo International by 12.7% during the 4th quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares during the last quarter. Rakuten Investment Management Inc. bought a new position in Mettler-Toledo International during the 3rd quarter worth approximately $121,021,000. Finally, Alliancebernstein L.P. raised its holdings in Mettler-Toledo International by 10.7% during the 3rd quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock worth $974,633,000 after purchasing an additional 76,478 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.